The Distinct Regulation of the Vitamin D and Aryl Hydrocarbon Receptors in COVID-19
Nutrients · 2024
DOI: 10.3390/nu16050598 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Nutrients, 2024. Verfasst von Oliver Robak und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine I, Medical University of Vienna, 1090 Vienna, Austria. Hauptthemen laut MEDLINE: Vitamin D, COVID-19. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Austrian Science Fund FWF, Austrian Science Fund, Medical-Scientific Fund of the Mayor of the Federal Capital Vienna.
Abstract (Originalsprache)
(1)
Background
SARS-CoV-2 affects several immune pathways, including the vitamin D (VDR) and the aryl hydrocarbon receptor pathways (AhR). The aim of the study was the evaluation of the VDR and AhR pathways in the blood of COVID-19 patients with regard to the severity of disease. (2)
Methods
Observational, single-center, case–control design. A total of 240 samples were selected for exploration. Patients who tested negative for SARS-CoV-2 but suffered from other respiratory infections (ORIs) served as a control group. (3)
Results
VDR-specific mRNA in the blood of patients with mild symptoms (131.2 ± 198.6) was significantly upregulated relative to the VDR expression of the ORI group (23.24 ± 42.60; p < 0.0001); however, VDR expression of critically ill patients showed an impaired upregulation (54.73 ± 68.34; p < 0.001). CYP27B1 expression was not significantly regulated during SARS-CoV-2 infection. There was a downregulation of VDR and CYP27B1 compared to survivors. There was no significant difference in 25(OH)-vitamin D3 levels between critically ill patients with regard to survival (24.3 ± 9.4 vs. 27.1 ± 11.3; p = 0.433). (4)
Conclusion
The VDR and AhR pathways are distinctively regulated in patients suffering from COVID-19 depending on the severity of disease. A combination treatment of antiviral drugs and vitamin D substitution should be evaluated for potentially improved prognosis in COVID-19.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine I, Medical University of Vienna, 1090 Vienna, Austria.
- Department of Laboratory Medicine, Klinik Landstraße, 1030 Vienna, Austria.
- Karl-Landsteiner Institute for Microbiome Research, Medical University of Vienna, 1090 Vienna, Austria.
ORCID-Profile: Oliver Robak, André Viveiros, Christoph Steininger
Förderung
- Austrian Science Fund FWF
- Austrian Science Fund
- Medical-Scientific Fund of the Mayor of the Federal Capital Vienna
Zitieren
APA
Robak, O., Kastner, M. T., Voill-Glaninger, A., Viveiros, A., & Steininger, C. (2024). The Distinct Regulation of the Vitamin D and Aryl Hydrocarbon Receptors in COVID-19. Nutrients. https://doi.org/10.3390/nu16050598
Vancouver
Robak O, Kastner MT, Voill-Glaninger A, Viveiros A, Steininger C. The Distinct Regulation of the Vitamin D and Aryl Hydrocarbon Receptors in COVID-19. Nutrients. 2024. doi:10.3390/nu16050598
BibTeX
@article{Robak2024,
author = {Robak, Oliver and Kastner, Marie-Theres and Voill-Glaninger, Astrid and Viveiros, André and Steininger, Christoph},
title = {The Distinct Regulation of the Vitamin D and Aryl Hydrocarbon Receptors in COVID-19},
journal = {Nutrients},
year = {2024},
doi = {10.3390/nu16050598}
}
EUVIMED